How To Engage With Gov't's Direct-To-Consumer Drug Policy
By Mary Kohler · March 12, 2026, 5:29 PM EDT
Last month, TrumpRx launched alongside significant pharmaceutical benefit manager reforms.[1] Whether these events ultimately lower drug prices remains uncertain, but they reflect a broader tech-enabled shift toward manufacturers interacting directly with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login